In an early Christmas gift for some, Chile and Mexico started immunizing on Thursday after granting emergency approval for the Pfizer / BioNTech vaccine. But in Brazil, where Covid-19’s death toll is much higher, vital inoculation could be out of reach for months – the country’s Ministry of Health announced last week that vaccinations would begin in February 2021.
As Brazil has a strong history of vaccination across the country, she says there was a widespread expectation that Brazilians would have a regional advantage in the battle against the pandemic.
“Brazil has always been a leader in the implementation of new vaccines. We managed to achieve high vaccination coverage, even though it is a continental country with very different regions, like São Paulo with a high population density and Amazonas, with huge distances, (e) an indigenous population “, she said.
“People expected the Brazilian vaccination program to start earlier,” she said. But “other countries in the Americas that have prepared themselves are already starting vaccination, and Brazil has been left behind”.
With more than 7.4 million people diagnosed with Covid-19 in Brazil and new variants of the virus appearing abroad, there is little reason to think that the pandemic is decreasing – a claim Bolsonaro made several times this year, even with the cases continuing to increase in the country. Only the USA and India reported more coronavirus infections than Brazil.
The Brazilian president also made headlines last week with a bizarre attempt to sow doubts about the potential side effects of the Pfizer vaccine. “If you become a crocodile, that’s your problem,” he warned. “If you become Superman, or grow a beard like a woman, or a man’s voice gets high, I have nothing to do with it … or worse, interfere with people’s immune systems.”
Pfizer did not respond to CNN’s request for comment.
Domingues believes that the Brazilian federal government was caught unprepared to use the Pfizer / BioNTech vaccine, after launching its support for a vaccine candidate from the University of Oxford and AstraZeneca, which have a partnership with the local foundation Fiocruz. According to a note released last week by the Ministry of Health, Brazil has agreed to purchase more than 100 million doses of this vaccine, which is still under development.
Meanwhile, fears about the influence of politics in the process, after a year of fierce clashes between Bolsonaro and state governors over the country’s pandemic response.
The president makes no secret of preferring the Oxford / AstraZeneca vaccine to a vaccine developed by Chinese manufacturer Sinovac Biotech, which has support from the state of São Paulo and is under local development with the Brazilian laboratory Instituto Butantan.
ANVISA and the Brazilian Ministry of Health did not respond to requests for comment.
Reporting contributed by Tatiana Arias, Jennifer Z. Deaton, Natalie Gallon and Stefano Pozzebon.